pharmaceuticals
pharmaceuticals Articles
A few biopharma companies have made massive runs on Tuesday morning.
Published:
Last Updated:
Valeant Pharmaceuticals received a key FDA approval early on Thursday, but it seems to be a mixed blessing.
Published:
Last Updated:
Merck saw its shares slip on Wednesday after the firm reported that it will be halting its mid-to-late-stage clinical trial for the treatment of Alzheimer’s disease.
Published:
Last Updated:
Evoke Pharma saw its shares jump on Wednesday after the company issued an update that it received from the FDA.
Published:
Last Updated:
Shares of Sage Therapeutics saw a handy gain on Monday after the company announced a successful mid-stage trial for the treatment of major depressive disorder.
Published:
Last Updated:
Zosano Pharma saw its shares absolutely skyrocket on Monday after the firm gave an update on its late-stage trial for the treatment of migraines.
Published:
Last Updated:
Teva beat estimates on earnings and revenues for both the quarter and the fiscal year and its outlook for 2017 is better than the consensus estimates.
Published:
Last Updated:
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
Published:
Last Updated:
Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made splash, while one giant company posted a massive loss.
Published:
Last Updated:
Teva Pharmaceutical saw its shares tumble on Tuesday after the company announced a changing of the guard. This CEO departure may have been long overdue.
Published:
Last Updated:
Neos Therapeutics saw its shares sink after the company announced that it had priced its secondary offering of common stock.
Published:
Last Updated:
Benitec Biopharma saw its shares more than double on Tuesday after the company gave a business update on its ddRNAi technology for the development of therapeutics for the treatment of ocular diseases.
Published:
Last Updated:
AMAG Pharmaceuticals shares took a sharp turn down after the company reported top-line results from its most recent pharmacokinetic study.
Published:
Last Updated:
Merck reported disappointing fourth-quarter financial results before the markets opened on Thursday.
Published:
Last Updated:
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) saw its shares make a huge gain on Tuesday after the firm reported a key legal decision in its favor. Essentially, the U.S. District Court for the...
Published:
Last Updated: